In This Article

The short answer: Insulin resistance develops silently over years before blood glucose ever looks problematic, because the pancreas compensates by producing more insulin to maintain normal glucose levels. By the time fasting glucose rises above 100 mg/dL, insulin resistance has typically been present for a decade. Your wearable data can show early signals: blunted HRV, elevated resting heart rate, declining VO2 max estimate, fragmented sleep, and energy crashes after meals, all years before a standard blood panel flags anything. Understanding these signals and what drives them gives you a long intervention window most people do not use.

Read key takeaways →

What insulin resistance actually is

Insulin resistance is not a binary state. It is a spectrum: a progressive decline in cellular sensitivity to insulin that forces the pancreas to secrete increasing amounts of the hormone to achieve the same glucose-clearing effect. In the early stages, normal fasting glucose is maintained only because insulin is elevated. The blood sugar looks fine; the insulin is working overtime. This is why fasting glucose alone is an inadequate screen.

The underlying mechanism involves the insulin receptor pathway inside cells. In healthy metabolism, insulin binds to its receptor on muscle, fat, and liver cells, triggering GLUT4 transporter expression that pulls glucose from the bloodstream. In insulin-resistant cells, this signaling cascade is impaired, most often due to intracellular fat accumulation that interferes with PI3K-Akt signaling. The result: glucose stays elevated longer, the pancreas detects this and releases more insulin, and the cycle reinforces itself over years.

The Hidden Progression

Years 1-5

Insulin rises

Glucose still normal

→

Years 5-10

Fasting glucose 90-99

Standard lab: normal

→

Years 10-15

Prediabetes

Fasting glucose 100-125

→

Later

Type 2 diabetes

Fasting glucose 126+

HOMA-IR (fasting glucose x fasting insulin / 405) detects insulin resistance years before fasting glucose rises. Optimal HOMA-IR is below 1.0; above 2.0 is insulin resistant by most definitions. Most standard panels do not include fasting insulin unless you request it.

Benjamin Bikman at Brigham Young University has done some of the clearest work explaining why fasting insulin, not fasting glucose, is the early detection marker. His research frames insulin as the upstream driver: elevated insulin precedes elevated glucose by years, and elevated insulin itself causes damage (promoting fat storage, driving inflammatory signaling, impairing endothelial function) even when glucose is normal.

What insulin resistance looks like in wearable data

No wearable measures insulin directly. But insulin resistance produces systemic effects that show up across multiple metrics simultaneously. The pattern, not any single number, is the signal.

Wearable Signals Associated With Insulin Resistance

Suppressed HRV

Autonomic dysfunction

Chronic hyperinsulinemia impairs autonomic nervous system function, reducing parasympathetic tone. Population studies consistently show lower HRV in insulin-resistant individuals compared to metabolically healthy controls at similar BMI and age. The mechanism involves oxidative stress and advanced glycation end-products damaging vagal nerve function.

Elevated resting heart rate

Sympathetic excess

Insulin resistance activates the sympathetic nervous system through multiple pathways including elevated free fatty acids and impaired baroreceptor sensitivity. A chronically elevated resting heart rate in the absence of training load changes or illness is one of the most accessible signals of systemic metabolic stress.

Declining VO2 max estimate

Metabolic inflexibility

Metabolic inflexibility from insulin resistance impairs fat oxidation capacity. At moderate exercise intensities, insulin-resistant individuals rely more heavily on carbohydrates even at intensities where healthy metabolism would primarily use fat. This reduces sustainable aerobic performance and produces the VO2 max decline wearables detect over time.

Fragmented sleep

Nocturnal glucose swings

Insulin resistance produces larger post-meal glucose spikes and more pronounced nocturnal glucose variability. Large nocturnal glucose swings activate the stress response, fragment sleep architecture, and reduce slow-wave sleep percentage. This is why people with insulin resistance often report sleeping "enough hours" but waking unrefreshed.

Post-meal energy crashes

Exaggerated glucose response

Reactive hypoglycemia (blood sugar crashing 2-3 hours after meals) is an early functional sign of insulin resistance, where an exaggerated insulin response to glucose overshoots and drives blood sugar below pre-meal levels. This shows as afternoon energy crashes, difficulty concentrating after lunch, and hunger cycling despite adequate calorie intake.

Common Misconception

Insulin resistance is not something only overweight people or people with a family history need to worry about. Athletes and lean individuals can be metabolically insulin-resistant if they have high visceral fat (which can be present with normal BMI), poor sleep, high chronic stress, or inadequate aerobic base. TOFI (thin outside, fat inside) is well documented in research. The metabolic state matters; body weight alone is not a reliable indicator.

Blood markers that detect it early

Standard annual labs typically include fasting glucose and a lipid panel. They miss insulin resistance until it is advanced. These additional markers, most available through standard labs when requested, identify insulin resistance years earlier.

Fasting insulin:
The single most important missing test. Optimal is below 5 uIU/mL; above 10 is problematic by functional medicine standards. Not included in standard panels. Ask specifically.
HOMA-IR:
Calculated from fasting glucose and fasting insulin (fasting glucose x fasting insulin / 405). Below 1.0 is optimal; above 2.0 is insulin resistant by most research definitions. Direct Services like Function Health and LabCorp Direct test this.
Triglyceride-to-HDL ratio:
A proxy for insulin resistance calculable from your existing lipid panel. Ratio above 3.5 is a strong insulin resistance signal. Above 2.0 warrants attention. The triglyceride-HDL ratio performs comparably to HOMA-IR for insulin resistance screening in several validation studies.
HbA1c:
Reflects 3-month average blood sugar. Optimal is below 5.4%; the clinical prediabetes cutoff of 5.7% is a trigger point, not the target. Values between 5.4-5.7% in a younger healthy adult deserve follow-up with fasting insulin.
Fasting glucose trend:
A single reading is less useful than the trend across years. Fasting glucose creeping from 82 to 88 to 94 over three consecutive annual tests is a meaningful signal even though each reading is "normal." The trend is the data.

For a full guide to interpreting metabolic biomarkers in context, the Lab Work and Biomarkers Protocol covers optimal ranges and what to request. For more on blood sugar stability and daily energy, see Why Blood Sugar Stability Matters Even If You Are Not Diabetic.

What actually reverses insulin resistance

Insulin resistance is not irreversible, and it does not require pharmaceutical intervention in early stages. The lifestyle levers are well established and work through distinct mechanisms. They can produce measurable HOMA-IR improvement within 4-12 weeks.

1

Zone 2 cardio (150+ min/week)

The highest-leverage intervention. Zone 2 training increases GLUT4 transporter expression in muscle cells and improves fat oxidation capacity, directly addressing the metabolic inflexibility at the core of insulin resistance. San Millan at University of Colorado has documented this mechanism in detail. Even 90 minutes per week produces measurable HOMA-IR improvement in sedentary individuals within 8 weeks.

2

Post-meal walking (10-15 minutes after eating)

Buffey et al. 2022 showed that a 10-minute walk after meals reduced 24-hour glucose area under the curve by 30% compared to sitting. Muscle contractions during walking drive GLUT4 expression independent of insulin signaling, providing a direct glucose disposal pathway that bypasses insulin resistance. This is one of the highest return-per-minute interventions available.

3

Strength training (2-4x/week)

Muscle mass is the largest glucose disposal organ in the body. Greater muscle mass increases baseline GLUT4 expression and resting glucose uptake. Schoenfeld et al. (2017) demonstrated dose-response relationship between training volume and hypertrophy. Each additional pound of muscle increases basal metabolic rate and improves insulin sensitivity even at rest.

4

Sleep quality and duration (7-9 hours)

Even partial sleep restriction (6 hours versus 8 hours) for one week reduces insulin sensitivity by 25-30% in healthy young adults (Nedeltcheva et al., 2009, Annals of Internal Medicine). This is one of the fastest ways to impair insulin sensitivity. Consistently getting adequate sleep is not optional if you are working to improve metabolic health.

5

Ultra-processed food reduction

Hall et al. 2019 NIH RCT showed that ad libitum ultra-processed food intake drove spontaneous consumption of approximately 500 extra calories per day compared to whole food matched conditions. The visceral fat accumulation from this excess is a primary driver of liver and muscle insulin resistance. Reducing ultra-processed food drives visceral fat loss, which directly improves insulin sensitivity over months.

Frequently asked questions

My fasting glucose is 92 mg/dL and my doctor says I am fine. Should I be concerned?

A fasting glucose of 92 is technically normal (below the 100 mg/dL prediabetes threshold), but it is above optimal. Functional medicine research targets below 90 mg/dL as optimal, and trends matter as much as any single number. If your glucose has been rising from 80 to 85 to 92 over three years, that trend warrants investigation even though you are "normal." Ask your doctor to add fasting insulin to your next panel. If your triglyceride-to-HDL ratio is above 2.0, that adds further reason to investigate HOMA-IR.

Can my wearable tell me about specific glucose spikes?

Standard wearables (Oura, WHOOP, Apple Watch, Garmin) cannot measure glucose directly. You would need a continuous glucose monitor (CGM) like Dexterity Biosensor, Lingo (Abbott), or Stelo (Dexcom) for actual glucose data. What standard wearables can show is the downstream effects of glucose instability: post-meal heart rate variability changes, energy level proxies (step count, activity signals), and sleep quality patterns that correlate with nocturnal glucose variability. Some people find using a CGM for 2-4 weeks informative as a dietary audit tool, even without diabetes or prediabetes.

Does intermittent fasting help insulin resistance?

Time-restricted eating (TRE) has a real but modest effect on insulin sensitivity. The mechanism is meaningful: limiting the feeding window reduces the total daily insulin secretion burden and may improve insulin receptor sensitivity over time. Sutton et al. 2018 showed that 5-week early TRE (eating within a 6-hour window, stopping by 3pm) improved insulin sensitivity independent of weight loss in men with prediabetes. But TRE is a tier-4 lever behind Zone 2 training, strength training, and sleep quality in terms of effect size. It is additive, not a replacement for the primary interventions.

Is insulin resistance genetic? Can I actually change it?

There is meaningful genetic variation in insulin sensitivity, but genetics explain a minority of population-level variance. The large majority of early-to-moderate insulin resistance is lifestyle-driven and lifestyle-reversible. Studies consistently show that structured aerobic and strength training plus sleep optimization can produce 30-40% improvements in HOMA-IR within 12 weeks in sedentary adults. The gene version you have matters less than what you do consistently over months and years. This is a behavior problem with genetic modifiers, not a genetic problem with behavior modifiers.

How long until I see wearable improvements after addressing insulin resistance?

Functional improvements (less post-meal energy crash, better afternoon energy) often appear within 2-4 weeks of consistent Zone 2 training and dietary changes. HRV improvement is slower: 4-8 weeks of consistent aerobic training typically produces measurable baseline shifts. VO2 max estimate improvements from metabolic flexibility gains take 8-16 weeks of consistent Zone 2 work. Blood marker changes (HOMA-IR, triglyceride-to-HDL) are typically visible at 8-12 week labs if interventions are consistent.

What to Remember

  • →Insulin resistance is present for roughly a decade before fasting glucose rises above 100 mg/dL, because the pancreas compensates with higher insulin output. Fasting glucose alone is an inadequate screen.
  • →HOMA-IR (fasting glucose x fasting insulin / 405) detects insulin resistance years before fasting glucose changes. Optimal is below 1.0; above 2.0 is resistant. Fasting insulin must be requested separately.
  • →Wearable signals of insulin resistance include chronically suppressed HRV, elevated resting heart rate, declining VO2 max estimate, and fragmented sleep with nocturnal glucose variability.
  • →A triglyceride-to-HDL ratio above 3.5 on your standard lipid panel is a strong insulin resistance proxy, calculable from numbers you already have.
  • →Zone 2 cardio at 150+ minutes per week is the highest-leverage intervention, improving insulin sensitivity through GLUT4 expression and metabolic flexibility within 8-12 weeks.
  • →Post-meal walking for 10-15 minutes reduces 24-hour glucose area under the curve by approximately 30% by driving GLUT4 expression independent of insulin signaling (Buffey et al., 2022).

Related on Protocol

LearnNutrition

Why Blood Sugar Stability Matters Even If You Are Not Diabetic

Glucose stability mechanisms, energy crashes, and what to do about them.

Read
ProtocolHealth

The Lab Work and Biomarkers Protocol

How to read your full lab panel, what to request, and optimal versus reference ranges.

Read
LearnTraining

What Your Step Count Actually Tells You About Metabolic Health

NEAT, daily movement volume, and metabolic health outcomes.

Read

Track the wearable signals of metabolic health over time

Protocol tracks your HRV baseline, resting heart rate, and VO2 max trend so you can see whether your metabolic health is improving, holding steady, or quietly declining before blood markers change.

Get started free

References

Key Researchers

  • Benjamin Bikman (Brigham Young University) Insulin resistance and hyperinsulinemia research. His work establishes fasting insulin as the critical early marker and frames insulin itself (not just glucose) as the driver of metabolic disease progression.
  • Inigo San Millan (University of Colorado) Metabolic flexibility and Zone 2 training. Has documented the GLUT4 and fat oxidation mechanisms by which Zone 2 aerobic training reverses metabolic inflexibility in insulin-resistant individuals.
  • Gerald Shulman (Yale University) Mechanisms of insulin resistance at the cellular level. His work on intramyocellular lipid accumulation impairing PI3K-Akt signaling provides the molecular basis for exercise-driven insulin sensitivity improvement.

Key Studies

  • Nedeltcheva et al. (2009) Annals of Internal Medicine. Sleep restriction to 5.5 hours per night for 14 days reduced insulin sensitivity by approximately 25-30% compared to 8.5 hours in healthy young adults. Established sleep as a primary insulin sensitivity lever.
  • Buffey et al. (2022) Sports Medicine. Meta-analysis and primary data showing post-meal walking for 10-15 minutes reduced 24-hour glucose area under the curve by approximately 30% and attenuated post-meal glucose peaks more effectively than a single equivalent-duration walk at other times.
  • Sutton et al. (2018) Cell Metabolism. 5-week RCT of early time-restricted eating (6-hour window, ending by 3pm) improved insulin sensitivity, blood pressure, and oxidative stress in men with prediabetes, independent of weight loss.
  • Hall et al. (2019) Cell Metabolism. NIH crossover RCT showing ad libitum ultra-processed food diet drove spontaneous overconsumption of approximately 500 kcal/day and visceral fat gain compared to matched whole food diet, establishing ultra-processed food as a primary driver of metabolic dysfunction.

Books

  • Why We Get Sick Benjamin Bikman (2020). Accessible book-length argument for fasting insulin as the primary metabolic marker. Strongest on the case for insulin as upstream driver of chronic disease; less comprehensive on training interventions.